PARE ANTHONY enters T2 BIOSYSTEMS, INC. with 4.58K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/29/2020ACC: 0000899243-20-002271
Officer· Chief Commercial Officer
Since Jan 2020
4.58K
Baseline shares
100% direct
4.58K
Direct ownership
1 position
350K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned4.58K
Total
4.58K direct4.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.58K | Direct |
| Total | 4.58K | 4.58K direct |
Derivative Holdings3
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
3.10
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
1.43
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
N/A
Exercise price
1.15
Expiration
—
Exercise window
—
Total
Underlying
350K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock | 3.10 | — | — | 100K | N/A |
| Stock Option Direct | Common Stock | 1.43 | — | — | 100K | N/A |
| Stock Option Direct | Common Stock | 1.15 | — | — | 150K | N/A |
| Total | 350K | 0.00 | ||||